VEGFA and colorectal carcinoma: In 2019, Cheng and colleagues [33] developed an ICG–bevacizumab complex (Bev-ICG) that targeted vascular endothelial growth factor (VEGF) for NIR-II-based endoscopic imaging of colorectal cancer (CRC) (Fig. 7B to D).